New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - cefuroxime sodium 1.578 g equivalent to 1.5 g cefuroxime;  ;   - powder for injection - 1.5 g - active: cefuroxime sodium 1.578 g equivalent to 1.5 g cefuroxime     - cefuroxime is a bactericidal cephalosporin antibiotic which is resistant to most ?-lactamases and is active against a wide range of gram-positive and gram-negative organisms. it is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. susceptibility to cefuroxime sodium will vary with geography and time and local susceptibility data should be consulted where available. indications include - respiratory tract infections for example, acute exacerbation of chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections. - ear, nose and throat infections for example, sinusitis, tonsillitis, pharyngitis and otitis media. - urinary tract infections for example, acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. - soft-tissue infections for example, cellulitis, erysipelas and wound infections. - bone and joint infections for example, osteomyelitis and septic ar

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - cefuroxime sodium 789mg equivalent to 750 mg cefuroxime;  ;   - powder for injection - 750 mg - active: cefuroxime sodium 789mg equivalent to 750 mg cefuroxime     - cefuroxime is a bactericidal cephalosporin antibiotic which is resistant to most ?-lactamases and is active against a wide range of gram-positive and gram-negative organisms. it is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. susceptibility to cefuroxime sodium will vary with geography and time and local susceptibility data should be consulted where available. indications include - respiratory tract infections for example, acute exacerbation of chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections. - ear, nose and throat infections for example, sinusitis, tonsillitis, pharyngitis and otitis media. - urinary tract infections for example, acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. - soft-tissue infections for example, cellulitis, erysipelas and wound infections. - bone and joint infections for example, osteomyelitis and septic ar

Israel - English - Ministry of Health

novartis israel ltd., israel - cefuroxime as sodium - powder for solution or suspension for injection or infusion - cefuroxime as sodium 750 mg/vial - cefuroxime - cefuroxime - therapeutic indications zinacef is indicated for the treatment of the infections listed below in adults and children, including neonates (from birth)• community acquired pneumonia• acute exacerbations of chronic bronchitis• complicated urinary tract infections, including pyelonephritis• soft-tissue infections: cellulitis, erysipelas and wound infections• intra-abdominal infections • prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and gynaecological surgery (including caesarean section) • nose infections for example, sinusitis • septic arthritis

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxosmithkline manufacturing spa - cefuroxime (cefuroxime sodium) - powder for solution for injection - 750mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxosmithkline manufacturing spa - cefuroxime (cefuroxime sodium) - powder for solution for injection - 750mg

Ireland - English - HPRA (Health Products Regulatory Authority)

sandoz pharmaceuticals d.d. - cefuroxime sodium - powder for solution for injection - second-generation cephalosporins; cefuroxime

Ireland - English - HPRA (Health Products Regulatory Authority)

sandoz pharmaceuticals d.d. - cefuroxime sodium - powder for solution for injection/infusion - second-generation cephalosporins; cefuroxime

Ireland - English - HPRA (Health Products Regulatory Authority)

sandoz pharmaceuticals d.d. - cefuroxime sodium - powder for solution for injection - second-generation cephalosporins; cefuroxime

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - cefuroxime sodium 262.5mg equivalent to 250 mg cefuroxime - powder for injection - 250 mg - active: cefuroxime sodium 262.5mg equivalent to 250 mg cefuroxime

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - cefuroxime sodium - powder for solution for injection - 250 milligram(s) - second-generation cephalosporins; cefuroxime